These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28359690)

  • 1. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery.
    Wethington SL; Barrena Medel NI; Wright JD; Herzog TJ
    Gynecol Oncol; 2009 Oct; 115(1):18-25. PubMed ID: 19632708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
    Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
    Seagle BL; Alexander AL; Lantsman T; Shahabi S
    Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
    Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
    Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of peritoneal cytology in uterine cervix and endometrial cancer.
    Kashimura M; Sugihara K; Toki N; Matsuura Y; Kawagoe T; Kamura T; Kaku T; Tsuruchi N; Nakashima H; Sakai H
    Gynecol Oncol; 1997 Dec; 67(3):285-90. PubMed ID: 9441776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study.
    Sun B; Zhang X; Dong Y; Li X; Yang X; Zhao L; Wang J; Cheng Y
    World J Surg Oncol; 2024 Jul; 22(1):203. PubMed ID: 39080611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study.
    Kwon JS; Carey MS; Cook EF; Qiu F; Paszat L
    Int J Gynecol Cancer; 2007; 17(2):433-40. PubMed ID: 17309565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
    Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
    Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.